tPA binds to fibrin in a blood clot and converts the inactive zymogen plasminogen into the active enzyme plasmin. Plasmin then degrades fibrin, the structural component of blood clots, into soluble fragments. This enzymatic activity is tightly regulated to prevent excessive bleeding, with inhibitors such as PAI-1 and alpha-2-antiplasmin modulating tPA activity.
